We are on an exciting journey. Keep up with us as we grow!

Born of a multidisciplinary collaboration between biologists and physicist at the University of Durham, UK, Magnitude Biosciences has expanded from an automated imaging spin-off to a fully-fledged pre-clinical contract services provider. Here’s what we’ve been up to along the way!

2020-10: CONFERENCE NEWS! Magnitude Biosciences is coming to ELRIG Drug Discovery Online. Access our poster and video for an overview of our ageing, neurodegenration and microbiome assays. 


2020-10: CONFERENCE NEWS! Magnitude Biosciences CEO, David Weinkove, has been confirmed as a Keynote speaker for the online London Microbiome Meeting. Check out the program!  


2020-08: FUNDING AWARDED! Magnitude Biosciences secures UK government Future Fund to expand its workforce. Read our Press Release!


2020-06: CONFERENCE NEWS! Magnitude Biosciences will be presenting at the online European Worm Meeting. Check out our video poster!  


2020-05: KEEP YOUR PROJECT GOING! Magnitude Biosciences' new COVID-19 compatible laboratory is fully operational and we are ready to support your research! 


2020-05: NEW SERVICES! Magnitude Biosciences now offers Transgenic Services and Training after acquiring Invermis Ltd. 


2020-05: MICROBIOME WEBINAR! Listen to our CEO, Dr. David Weinkove, explain how Magnitude Biosciences' technology can help researchers in the Microbiome field.


2020-03: CONFERENCE NEWS! Magnitude Biosciences will be pleased to attend Vermidi 23 online, co-ordinated from the Sorbonne, Paris. 


2019-12: FUNDING AWARDED! Magnitude Biosciences secures its second round of funding to support its pre-clinical research services.


2019-01: LAUNCH! Magnitude Biosciences enters the world of Contract Research Services, as a spin-out from Durham University, UK.

Will you become part of our story?
Can we help make your project a success?
Check out our Research Services and Testimonials pages!